Relay Therapeutics, Inc. (RLAY)

Relay Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Sep 30, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Cash & Equivalents	152.36	143.74	151.79	280.12	447.65	41.95
Short-Term Investments	687.25	606.35	847.12	677.95	230.42	313.86
Cash & Short-Term Investments	839.61	750.09	998.92	958.07	678.06	355.82
Cash Growth	3.58%	-24.91%	4.26%	41.30%	90.57%	-15.58%
Receivables	-	-	5.22	4.94	82.65	-
Prepaid Expenses	18.73	16.7	12.11	11.47	9.39	4.72
Other Current Assets	6.8	3.32	3.26	1.76	-	-
Total Current Assets	865.13	770.1	1,020	976.24	770.1	360.54
Property, Plant & Equipment	60.57	68.87	75.39	27.32	28.83	31.65
Other Intangible Assets	2.3	2.3	2.3	2.3	-	-
Other Long-Term Assets	2.12	2.71	2.58	2.58	0.9	0.88
Total Assets	930.12	843.98	1,100	1,008	799.83	393.07
Accounts Payable	6.87	9.21	10.58	8.28	6.35	6.99
Accrued Expenses	33.22	14.89	22.7	13.56	5.56	3.41
Current Portion of Leases	5.53	4.96	4.28	1.84	1.52	1.25
Current Unearned Revenue	-	-	-	0.25	-	-
Other Current Liabilities	1.36	1.2	26.15	0.4	0.2	0.33
Total Current Liabilities	46.97	30.27	63.71	24.32	13.63	11.99
Long-Term Leases	44.29	48.5	53.47	21.06	22.9	23.58
Other Long-Term Liabilities	-	13.21	32.38	65.26	0	0.16
Total Liabilities	91.25	91.98	149.55	110.64	36.54	35.73
Common Stock	0.17	0.13	0.12	0.11	0.09	0
Additional Paid-In Capital	2,498	2,153	2,019	1,667	1,167	8.72
Retained Earnings	-1,662	-1,401	-1,059	-768.1	-404.23	-189.48
Comprehensive Income & Other	2.51	-0.2	-10.42	-1.09	0.06	0.33
Total Common Equity	838.86	752	950.22	897.81	763.29	-180.44
Shareholders' Equity	838.86	752	950.22	897.81	763.29	357.34
Total Liabilities & Equity	930.12	843.98	1,100	1,008	799.83	393.07
Total Debt	49.82	53.47	57.74	22.9	24.42	24.83
Net Cash (Debt)	789.79	696.62	941.18	935.17	653.64	330.98
Net Cash Growth	4.47%	-25.98%	0.64%	43.07%	97.48%	-21.44%
Net Cash Per Share	5.98	5.68	8.39	9.83	15.34	95.92
Filing Date Shares Outstanding	167.38	131.18	121.38	108.28	90.32	86.59
Total Common Shares Outstanding	166.89	127.46	121.11	108.21	89.91	4.04
Working Capital	818.16	739.83	955.8	951.92	756.47	348.55
Book Value Per Share	5.03	5.90	7.85	8.30	8.49	-44.69
Tangible Book Value	836.56	749.7	947.92	895.51	763.29	-180.44
Tangible Book Value Per Share	5.01	5.88	7.83	8.28	8.49	-44.69
Machinery	-	29.08	24.98	17.88	15.32	13.73
Construction In Progress	-	1.58	1.22	0.13	0.58	0.49
Leasehold Improvements	-	3.83	3.83	2.9	0.89	0.86

Source: S&P Capital IQ. Standard template. Financial Sources.